TCG Crossover Management, LLC
CIK: 0001839948SEC EDGAR →
Portfolio Value
$3.0B
Holdings
43
As of
Q4 2025
New Positions
11
Closed Positions
8
Portfolio Value History
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | ABIVAX SA AMERICAN DEPOSITARY SHARES | 7,111,596 | $959.0M | 31.74% |
| 2 | COGENT BIOSCIENCES INC | 5,868,162 | $208.4M | 6.90% |
| 3 | CG ONCOLOGY INC | 3,670,206 | $152.4M | 5.04% |
| 4 | TANGO THERAPEUTICS INC | 12,762,094 | $113.1M | 3.74% |
| 5 | CENTESSA PHARMACEUTICALS PLC | 4,286,480 | $107.2M | 3.55% |
| 6 | DYNE THERAPEUTICS INC | 4,615,144 | $90.3M | 2.99% |
| 7 | RAPT THERAPEUTICS INC | 2,582,408 | $87.5M | 2.89% |
| 8 | TYRA BIOSCIENCES INC | 2,898,103 | $76.2M | 2.52% |
| 9 | AMYLYX PHARMACEUTICALS INC | 6,243,812 | $75.4M | 2.50% |
| 10 | SAVARA INC | 12,362,205 | $74.5M | 2.47% |
Quarterly Changes
New Positions (8)
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 42 | $2.9B | 97.5% |
| Unknown | 1 | $74.5M | 2.5% |